Endocrine-exocrine signaling drives obesity-associated pancreatic ductal adenocarcinoma
Katherine Minjee Chung,
Kimberly Judith Dorans,
Daniel B Burkhardt,
Sara A. Vayrynen,
Andressa Dias Costa,
Jonathan A. Nowak,
Daniel T. Chang,
Richard F. Dunne,
Aram F. Hezel,
Albert C Koong,
Joshua J. Wilhelm,
Melena D. Bellin,
Anna L. Gloyn,
Mark I McCarthy,
Richard G. Kibbey,
Brian M. Wolpin,
Charles S Fuchs,
Mandar Deepak Muzumdar
Posted 21 Jun 2019
bioRxiv DOI: 10.1101/663583 (published DOI: 10.1016/j.cell.2020.03.062)
Posted 21 Jun 2019
Obesity is a major modifiable risk factor for pancreatic ductal adenocarcinoma (PDAC), yet how and when obesity contributes to PDAC progression is not well understood. Leveraging an autochthonous mouse model, we demonstrate a causal and reversible role for obesity in early PDAC progression, showing that obesity markedly enhances tumorigenesis, while genetic or dietary induction of weight loss intercepts cancer development. Bulk and single cell molecular analyses of human and murine samples define microenvironmental consequences of obesity that promote tumor development rather than new driver gene mutations. We observe increased inflammation and fibrosis and also provide evidence for significant pancreatic islet cell adaptation in obesity-associated tumors. Specifically, we identify aberrant islet beta cell expression of the peptide hormone cholecystokinin (CCK) in tumors as an adaptive response to obesity. Furthermore, beta cell CCK expression promotes oncogenic Kras -driven pancreatic ductal tumorigenesis. Our studies argue that PDAC progression is driven by local obesity-associated changes in the tumor microenvironment – rather than systemic effects – and implicate endocrine-exocrine signaling beyond insulin in PDAC development. Furthermore, our demonstration that these obesity-associated adaptations are reversible supports the use of anti-obesity strategies to intercept PDAC early during progression.
- Downloaded 878 times
- Download rankings, all-time:
- Site-wide: 25,449
- In cancer biology: 639
- Year to date:
- Site-wide: 47,952
- Since beginning of last month:
- Site-wide: 50,880
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!